Coinspeaker GSK Stock Up 1.25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine BoosterAfter GlaxoSmithKline announced its plans to produce 1 billion doses of a vaccine adjuvant next year, the GSK stock price started to rise.GSK Stock Up 1.25%, GlaxoSmithKline Plans to Make 1B Doses of Coronavirus Vaccine Booster